Literature DB >> 34061307

Benchtop Isolation and Characterisation of Small Extracellular Vesicles from Human Mesenchymal Stem Cells.

Wui Chuen Chia1, Kian Leong Tan2, Chee Wun How3, Yin Sim Tor2,4, Pau Loke Show5, Qi Hao Daniel Looi6,7,8, Jhi Biau Foo9,10.   

Abstract

The objective of this study is to develop a simple protocol to isolate and characterise small extracellular vesicles (sEVs) from human umbilical cord-derived MSCs (hUC-MSCs). hUC-MSCs were characterised through analysis of morphology, immunophenotyping and multidifferentiation ability. SEVs were successfully isolated by ultrafiltration from the conditioned medium of hUC-MSCs. The sEVs' size distribution, intensity within a specific surface marker population were measured with zetasizer or nanoparticle tracking analysis. The expression of surface and internal markers of sEVs was also assessed by western blotting. Morphology of hUC-MSCs displayed as spindle-shaped, fibroblast-like adherent cells. Phenotypic analysis by flow cytometry revealed that hUC-MSCs expressed MSC surface marker, including CD90, CD73, CD105, CD44 and exhibited the capacity for osteogenic, adipogenic and chondrogenic differentiation. Populations of sEVs with CD9, CD63 and CD81 positive were detected with size distribution in the diameter of 63.2 to 162.5 nm. Typical sEVs biomarkers such as CD9, CD63, CD81, HSP70 and TSG101 were also detected with western blotting. Our study showed that sEVs from hUC-MSCs conditioned medium were successfully isolated and characterised. Downstream application of hUC-MSCs-sEVs will be further explored.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Exosome; Mesenchymal stem cell; NTA; Regeneration; Small extracellular vesicle

Mesh:

Substances:

Year:  2021        PMID: 34061307     DOI: 10.1007/s12033-021-00339-2

Source DB:  PubMed          Journal:  Mol Biotechnol        ISSN: 1073-6085            Impact factor:   2.695


  3 in total

1.  Isolation and characterization of exosomes from cell culture supernatants and biological fluids.

Authors:  Clotilde Théry; Sebastian Amigorena; Graça Raposo; Aled Clayton
Journal:  Curr Protoc Cell Biol       Date:  2006-04

Review 2.  Exosomes as biomarkers and therapeutic tools for type 1 diabetes mellitus.

Authors:  M Garcia-Contreras; R W Brooks; L Boccuzzi; P D Robbins; C Ricordi
Journal:  Eur Rev Med Pharmacol Sci       Date:  2017-06       Impact factor: 3.507

Review 3.  Exosomes and Their Therapeutic Potentials of Stem Cells.

Authors:  Chao Han; Xuan Sun; Ling Liu; Haiyang Jiang; Yan Shen; Xiaoyun Xu; Jie Li; Guoxin Zhang; Jinsha Huang; Zhicheng Lin; Nian Xiong; Tao Wang
Journal:  Stem Cells Int       Date:  2015-12-06       Impact factor: 5.443

  3 in total
  16 in total

1.  Yin Yang 1-induced activation of LINC01133 facilitates the progression of pancreatic cancer by sponging miR-199b-5p to upregulate myelin regulatory factor expression.

Authors:  Xi Yang; Leiming Wang; Fei Zhou; Song Ye; Qianghu Sun
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

2.  MiR-19a suppresses ferroptosis of colorectal cancer cells by targeting IREB2.

Authors:  Hongwei Fan; Rong Ai; Suen Mu; Xuemin Niu; Zhengrong Guo; Lin Liu
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

3.  Long non-coding RNA TRPM2 antisense RNA as a potential therapeutic target promotes tumorigenesis and metastasis in esophageal cancer.

Authors:  Wei Wang; Yukai Dai; Xin Yang; Xinming Xiong
Journal:  Bioengineered       Date:  2022-02       Impact factor: 6.832

Review 4.  Mesenchymal Stem Cell-Derived Exosomes and MicroRNAs in Cartilage Regeneration: Biogenesis, Efficacy, miRNA Enrichment and Delivery.

Authors:  Jhi Biau Foo; Qi Hao Looi; Chee Wun How; Sau Har Lee; Maimonah Eissa Al-Masawa; Pei Pei Chong; Jia Xian Law
Journal:  Pharmaceuticals (Basel)       Date:  2021-10-28

5.  Sevoflurane induces inflammation in primary hippocampal neurons by regulating Hoxa5/Gm5106/miR-27b-3p positive feedback loop.

Authors:  Zifu Zhu; Li Ma
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

Review 6.  Current status of clinical trials assessing mesenchymal stem cell therapy for graft versus host disease: a systematic review.

Authors:  Ying Li; Jie Hao; Zheng Hu; Yong-Guang Yang; Qi Zhou; Liguang Sun; Jun Wu
Journal:  Stem Cell Res Ther       Date:  2022-03-04       Impact factor: 6.832

7.  N6-methyladenosine (m6A)-mediated lncRNA DLGAP1-AS1enhances breast canceradriamycin resistance through miR-299-3p/WTAP feedback loop.

Authors:  Tao Huang; Lili Cao; Ningning Feng; Bo Xu; Yujin Dong; Min Wang
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

8.  The anti-fibrotic agent nintedanib protects chondrocytes against tumor necrosis factor-ɑ (TNF-ɑ)-induced extracellular matrix degradation.

Authors:  Chuankun Wang; Lizhe Qu
Journal:  Bioengineered       Date:  2022-03       Impact factor: 3.269

9.  Oncological Properties of Intravenous Leiomyomatosis: Involvement of Mesenchymal Tumor Stem-Like Cells.

Authors:  Saya Tamura; Takuma Hayashi; Hideki Tokunaga; Nobuo Yaegashi; Kaoru Abiko; Ikuo Konishi
Journal:  Curr Issues Mol Biol       Date:  2021-09-19       Impact factor: 2.976

10.  Exosomes loaded with programmed death ligand-1 promote tumor growth by immunosuppression in osteosarcoma.

Authors:  Lei Zhang; Lili Xue; Yanjuan Wu; Qilong Wu; Hongwei Ren; Xiang Song
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.